The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Purpose To study the uptake of biodegradable microparticles in Caco-2 cells.Methods Biodegradable microparticles of polylactic polyglycolic acid co-polymer (PLGA 50:50) of mean diameters 0.1 micron, 1 micron, and 10 microns containing bovine serum albumin as a model protein and 6-coumarin as a fluorescent marker were formulated by a multiple emulsion technique. The Caco-2 cell monolayers were incubated with each diameter microparticles (100 micrograms/ml) for two hours. The microparticle uptake in Caco-2 cells was studied by confocal microscopy and also by quantitating the 6-coumarin content of the microparticles taken up by the cells. The effects of microparticle concentration, and incubation time and temperature on microparticle cell uptake were also studied.Results The study demonstrated that the Caco-2 cell microparticle uptake significantly depends upon the microparticle diameter. The 0.1 micron diameter microparticles had 2.5 fold greater uptake on the weight basis than the 1 micron and 6 fold greater than the 10 microns diameter microparticles. Similarly in terms of number the uptake of 0.1 micron diameter microparticles was 2.7 x 10(3) fold greater than the 1 micron and 6.7 x 10(6) greater than the 10 microns diameter microparticles. The efficiency of uptake of 0.1 micron diameter microparticles at 100 micrograms/ml concentration was 41% compared to 15% and 6% for the 1 micron and the 10 microns diameter microparticles, respectively. The Caco-2 cell microparticle (0.1 micron) uptake increased with concentration in the range of 100 micrograms/ml to 500 micrograms/ml which then reached a plateau at higher concentration. The uptake of microparticles increased with incubation time, reaching a steady state at two hours. The uptake was greater at an incubation temperature of 37 degrees C compared to at 4 degrees C.Conclusions The Caco-2 cell microparticle uptake was microparticle diameter, concentration, and incubation time and temperature dependent. The small diameter microparticles (0.1 micron) had significantly greater uptake compared to larger diameter microparticles. The results thus suggest that the mechanism of uptake of microparticles in Caco-2 cell is particle diameter dependent. Caco-2 cells are used as an in vitro model for gastrointestinal uptake, and therefore the results obtained in these studies could be of significant importance in optimizing the microparticle-based oral drug delivery systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The capacity of transcytosis through the intestinal epithelial layer depends on the size, with a particle size of below 1 μm for optimal M-cell absorption [30], but also on the charge and hydrophilicity of the particle carrier [31–33].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [32]
Citations
Cites
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Self-citationArtursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844
Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Nano- and microparticles for the delivery of polypeptides and proteins
Couvreur, P., & Puisieux, F. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90046-7 · Cited by 281
A Novel Approach to the Oral Delivery of Micro- or Nanoparticles
Bodmeier, R., Chen, H., & Paeratakul, O. (1989) · Pharmaceutical Research · doi:10.1023/a:1015987516796 · Cited by 276
Walter, E., Janich, S., Roessler, B. J., Hilfinger, J. M., & Amidon, G. L. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960110x · Cited by 273
Self-citationThe Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies
Audus, K. L., Bartel, R. L., Hidalgo, I. J., & Borchardt, R. T. (1990) · Pharmaceutical Research · doi:10.1023/a:1015800312910 · Cited by 267
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
Florence, A. T., Hillery, A. M., Hussain, N., & Jani, P. U. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00059-h · Cited by 260
Peroral administration of nanoparticles
Kreuter, J. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90048-h · Cited by 207
Research works printed but not linked: 2
- J. Kreuter. J. Anat. 189:503–505, 1996.
- R. H. Muller. Colloidal Carriers for Controlled Drug Delivery and Targeting CRC Press, Boston, 1991.
Cited by
Items 301–400 of 872
Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain
Lin, Y., Pan, Y., Shi, Y., Huang, X., Jia, N., & Jiang, J. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/16/165101 · Cited by 62
Wen, A. M., Rambhia, P. H., French, R. H., & Steinmetz, N. F. (2013) · Journal of Biological Physics · doi:10.1007/s10867-013-9314-z · Cited by 68
Deng, Y., Xu, H., Huang, K., Yang, X., Xie, C. M., & Wu, J. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0885 · Cited by 60
Ertl, B., Heigl, F., Wirth, M., & Gabor, F. (2000) · Journal of Drug Targeting · doi:10.3109/10611860008996863 · Cited by 60
Madan, J., Dhiman, N., Sardana, S., Aneja, R., Chandra, R., & Katyal, A. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834159b8 · Cited by 59
Hu, Q., Wang, T., Zhou, M., Xue, J., & Luo, Y. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.07.089 · Cited by 59
López, T. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s13223 · Cited by 59
Rabha, B., Bharadwaj, K. K., Baishya, D., Sarkar, T., Edinur, H. A., & Pati, S. (2021) · Polymers · doi:10.3390/polym13081322 · Cited by 62
“The cellular uptake of nanoparticles is also dependent on the nanoparticle size [45,46].”
BackgroundOxygen Nanobubble Tracking by Light Scattering in Single Cells and Tissues
Bhandari, P. N., Wang, X., & Irudayaraj, J. (2017) · ACS Nano · doi:10.1021/acsnano.6b07478 · Cited by 57
Yang, S., Chang, J., Shin, B.-C., Park, S., Na, K., & Shim, C. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm01544j · Cited by 57
Неганова, М. Е., Aleksandrova, Y. R., Sukocheva, O. A., & Klochkov, S. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.011 · Cited by 58
Supersaturation induced by Itraconazole/Soluplus® micelles provided high GI absorption in vivo
Zhong, Y., Jing, G., Tian, B., Huang, H., Zhang, Y., Gou, J., Tang, X., He, H., & Wang, Y. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2015.07.001 · Cited by 56
“It has been reported that size is an important parameter controlling the internalization of nanoparticles into epithelia of the GI tract, and nanoparticles less than 100 nm in diameter have been detected in the intestinal mucosa and gutassociated lymphoid tissues and 500 nm particles have been found in the intestinal…”
BackgroundHagiwara, K., Nakata, M., Koyama, Y., & Sato, T. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.040 · Cited by 57
Novel core-shell lipid-chitosan and lipid-poloxamer nanocapsules: stability by hydration forces
Santander-Ortega, M. J., Lozano, M. V., Bastos‐González, D., Peula-García, J. M., & Ortega-Vinuesa, J. L. (2009) · Colloid & Polymer Science · doi:10.1007/s00396-009-2132-y · Cited by 56
Bao, H., Li, L., & Zhang, H. (2008) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2008.09.003 · Cited by 54
Ghosh, P., Bag, S., Roy, A. S., Subramani, E., Chaudhury, K., & Dasgupta, S. (2016) · RSC Advances · doi:10.1039/c6ra20441d · Cited by 57
Thiry, J., Kok, M. G. M., Collard, L., Frère, A., Krier, F., Fillet, M., & Évrard, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.12.001 · Cited by 55
Microsphere size effects on embryoid body incorporation and embryonic stem cell differentiation
Carpenedo, R. L., Seaman, S. A., & McDevitt, T. C. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32710 · Cited by 53
Liu, G., Yang, J., Wang, Y., Liu, X., Guan, L. L., & Chen, L. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2018.12.020 · Cited by 53
Huang, L., Liang, W., Zhou, K., Wassel, R. A., Ridge, Z., Ma, J., & Wang, B. (2021) · Biology · doi:10.3390/biology10121328 · Cited by 62
“In addition, nanoparticles have relatively higher intracellular uptake after delivery to tissues [43,44].”
BackgroundIn vitro release testing methods for vitamin E nanoemulsions
Morais, J. M., & Burgess, D. J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.063 · Cited by 52
Intestinal uptake of barley protein-based nanoparticles for β-carotene delivery
Liu, G., Zhou, Y., & Chen, L. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.10.002 · Cited by 52
Yang, G., Wu, F., Chen, M., Jin, J., Wang, R., & Yuan, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s194934 · Cited by 52
“In vitro cytotoxicity The human colon adenocarcinoma cell line, Caco-2 cells, have features similar to the absorptive intestinal cells, such as microvilli, the carrier-mediated transport systems, and paracellular transport through the tight junctions.(25) Therefore, the Caco-2 cells were used to study the effect of di…”
Food protein-based microspheres for increased uptake of vitamin D3
Diarrassouba, F., Garrait, G., Remondetto, G. E., Alvarez, P. A., Beyssac, E., & Subirade, M. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.10.112 · Cited by 51
Europium-Doped TiO2 Hollow Nanoshells: Two-Photon Imaging of Cell Binding
Sandoval, S., Yang, J., Alfaro, J. G., Liberman, A., Makale, M., Chiang, C. E., Schuller, I. K., Kummel, A. C., & Trogler, W. C. (2012) · Chemistry of Materials · doi:10.1021/cm302642g · Cited by 53
Nanosuspensions: a new approach for organ and cellular targeting in infectious diseases
Shegokar, R. (2013) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-013-0051-x · Cited by 51
“It is well known that cellular uptake is greater for nanoparticles compared to microparticles (Desai et al. 1997; Kanni 2006).”
BackgroundCheng, M., De, B., Almstead, N. G., Pikul, S., Dowty, M. E., Dietsch, C. R., Dunaway, C. M., Gu, F., Hsieh, L. C., Janusz, M. J., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9904699 · Cited by 51
Bamigbade, G. B., Abdin, M., Subhash, A. J., Arachchi, M. J. P., Ullah, N., Gan, R., Ali, A. H., Kamal‐Eldin, A., & Ayyash, M. M. (2025) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70156 · Cited by 51
“For biomedical applications, smaller NPs exhibit enhanced cellular uptake and biodistribution compared to larger particles (Desai et al., 1997).”
Abbasi, S. Q., Paul, A., & Prakash, S. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9201-9 · Cited by 50
“Changing the HSA concentration affects the size of the nanoparticles, thereby influencing transfection efficiency as smaller sized nanoparticles are more easily internalized by cells [34, 35].”
BackgroundAkagi, T., Kaneko, T., Kida, T., & Akashi, M. (2006) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856206777996871 · Cited by 53
Subirade, M., & Chen, L. (2008) · Elsevier eBooks · doi:10.1533/9781845694210.2.251 · Cited by 49
Prabu, P., Chaudhari, A. A., Dharmaraj, N., Khil, M., Park, S. Y., & Kim, H. Y. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32163 · Cited by 49
“High absolute value of zeta potential indicates high electric charge on the surface of the drug-loaded NPs (Table II), which can cause strong repellent forces among particles to prevent aggregation of the NPs.(33) The vinblastineloaded PGD NPs were found to be negatively charged with an average value ranges from 213.”
BackgroundPaukner, S., Köhl, G., Jalava, K., & Lubitz, W. (2003) · Journal of drug targeting · doi:10.1080/10611860310001593366 · Cited by 49
Bioreducible poly(amidoamine)s as carriers for intracellular protein delivery to intestinal cells
Cohen, S. J., Coué, G. M. J. P. C., Beno, D., Korenstein, R., & Engbersen, J. F. J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.085 · Cited by 48
Farid, M. M., Hathout, R. M., Fawzy, M., & Abou‐Aisha, K. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.10.045 · Cited by 48
Alfei, S., Marengo, B., & Domenicotti, C. (2020) · Antioxidants · doi:10.3390/antiox9010050 · Cited by 49
“In this regard, in a reported study [82], drug delivery systems with 100 nm nanoparticles exhibited a 2.”
BackgroundPlausible role of chitosan in drug and gene delivery against resistant breast cancer cells
Nandgude, T. D., & Pagar, R. R. (2021) · Carbohydrate Research · doi:10.1016/j.carres.2021.108357 · Cited by 48
The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells
Jin, C. S., Wu, H., Liu, J., Bai, L., & Guo, G. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00796.x · Cited by 48
“It was reported that smaller particles tended to accumulate in the tumour sites because of the facilitated extravasation (21) and a greater internalization was also observed (22).”
BackgroundWalter, F., Schöll, I., Untersmayr, E., Ellinger, A., Boltz-Nitulescu, G., Scheiner, O., Gabor, F., & Jensen-Jarolim, E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.057 · Cited by 47
Polyelectrolyte Complexes in the Dispersed and Solid State I: Principles and Theory
Müller, M. (2013) · Advances in polymer science · doi:10.1007/978-3-642-40734-5 · Cited by 65
Optimization of the Preparation Process for an Oral Phytantriol-Based Amphotericin B Cubosomes
Yang, Z., Peng, X., Tan, Y., Chen, M., Zhu, X., Feng, M., Xu, Y., & Wu, C. (2011) · Journal of Nanomaterials · doi:10.1155/2011/308016 · Cited by 54
Al-Beitawi, N. A., Shaker, M. M., El-Shuraydeh, K. N., & Bláha, J. (2016) · Journal of Applied Animal Research · doi:10.1080/09712119.2016.1221827 · Cited by 47
“Desai et al. (1997) observed that the nano form of supplementation increases surface area, which possibly could increase absorption and thereby utilization of minerals reflected in improving growth performance of broiler chickens. Moreover, Weiss et al. (2006) recorded that ingredients’ nanoparticle size might increas…”
BackgroundResultInfluentialNanomedicine for delivery of therapeutic molecules
Nimesh, S., & Gupta, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100557-6.00001-8 · Cited by 47
Chaves, L. L., Lima, S. A. C., Vieira, A. C. C., Barreiros, L., Segundo, M. A., Ferreira, D., Sarmento, B. F. C. C., & Reis, S. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.11.004 · Cited by 47
Beconcini, D., Felice, F., Fabiano, A., Sarmento, B. F. C. C., Zambito, Y., & Stefano, R. D. (2020) · Foods · doi:10.3390/foods9020207 · Cited by 50
“, in the liver), and are generally taken up efficiently by cells [74], thus allowing the efficient delivery of active compounds to target sites in the body.”
BackgroundHarde, H., Agrawal, A. K., & Jain, S. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1449-5 · Cited by 46
Gaihre, B., Aryal, S., Khil, M., & Kim, H. Y. (2008) · Journal of Microencapsulation · doi:10.1080/02652040701737697 · Cited by 46
“…the size and stability of the composite nanoparticles, which are the most important properties to enhance the cellular uptake, blood circulation time as well as bioavailability of the nanoparticles within the body (Gupta and Hung 1989; Desai et al. 1997; Leong et al. 1998; Zauner et al. 2001).”
BackgroundDevelopment of PLGA-Mannosamine Nanoparticles as Oral Protein Carriers
Alonso-Sande, M., Rieux, A. D., Fiévez, V., Sarmento, B. F. C. C., Delgado, A., Évora, C., Remuñán‐López, C., Préat, V., & Alonso, M. J. (2013) · Biomacromolecules · doi:10.1021/bm401141u · Cited by 50
Characterization of Different Functionalized Lipidic Nanocapsules as Potential Drug Carriers
Sánchez‐Moreno, P., Ortega-Vinuesa, J. L., Martín-Rodríguez, A., Boulaiz, H., Marchal, J. A., & Peula-García, J. M. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13022405 · Cited by 46
“nanoparticles, the drug release, the targeting ability, and their colloidal stability [31,32].”
Wang, M. Q., Wang, C., Du, Y., Li, H., Tao, W., Ye, S. S., He, Y., & Chen, S. Y. (2014) · Livestock Science · doi:10.1016/j.livsci.2013.12.029 · Cited by 46
“, 1996), and considerably greater uptake of small diameter microparticles and size dependency of uptake were confirmed in Caco-2 cell lines (Desai et al., 1997).”
BackgroundShen, Y., Chen, J. Y., Liu, Q., Feng, C., Gao, X., Wang, L., Zhang, Q., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.026 · Cited by 48
Lai, Y., Chiang, P., Blom, J. D., Li, N., Shevlin, K. M., Brayman, T. G., Hu, Y., Selbo, J. G., & Hu, L. (2008) · Nanoscale Research Letters · doi:10.1007/s11671-008-9160-2 · Cited by 46
Jahn, M., Nawroth, T., Fütterer, S., Wolfrum, U., Kolb, U., & Langguth, P. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200628u · Cited by 48
Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines
Brayden, D. J., & O’Mahony, D. J. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00075-3 · Cited by 45
Nagaonkar, D., Gaikwad, S. C., & Rai, M. (2015) · Colloid & Polymer Science · doi:10.1007/s00396-015-3538-3 · Cited by 45
“5–250-fold greater than particles exceeding the nanometer scale [9].”
BackgroundRevolutionary Impact of Nanodrug Delivery on Neuroscience
Khanbabaie, R., & Jahanshahi, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143513 · Cited by 42
Raemy, D. O., Limbach, L. K., Rothen‐Rutishauser, B., Grass, R. N., Gehr, P., Birbaum, K., Brandenberger, C., Günther, D., & Stark, W. J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.017 · Cited by 44
Poly(lactide-co-glycolide) nanoparticles for peroral delivery of bioactives
Grama, C. N., Ankola, D. D., & Kumar, M. N. V. R. (2010) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.11.005 · Cited by 45
Development of Clay Nanoparticles Toward Bio and Medical Applications
Mousavi, S. M., Hashemi, S. A., Salahi, S., Hosseini, M., Amani, A. M., & Babapoor, A. (2018) · InTech eBooks · doi:10.5772/intechopen.77341 · Cited by 44
The conjugation strategy affects antibody orientation and targeting properties of nanocarriers
Brückner, M., Simon, J., Landfester, K., & Mailänder, V. (2021) · Nanoscale · doi:10.1039/d0nr08191d · Cited by 47
Hartig, S. M., Carlesso, G., Davidson, J. M., & Prokop, A. (2006) · Biomacromolecules · doi:10.1021/bm0604754 · Cited by 44
Sankalia, M. G., Mashru, R. C., Sankalia, J. M., & Sutariya, V. B. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20665 · Cited by 44
Functionalization of nanoparticles in specific targeting and mechanism release
Adamo, G., Campora, S., & Ghersi, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46142-9.00003-7 · Cited by 59
Sims, L. B., Huss, M. K., Frieboes, H. B., & Steinbach-Rankins, J. M. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0298-x · Cited by 44
Trif, M., Florian, P. E., Roșeanu, A., Moisei, M., Crăciunescu, O., Astete, C. E., & Sabliov, C. M. (2015) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35498 · Cited by 45
Vihola, H., Marttila, A.-M., PAKKANEN, J., Andersson, M. R., Laukkanen, A., Kaukonen, A. M., Tenhu, H. J., & Hirvonen, J. J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.020 · Cited by 43
Ditto, A. J., Shah, K. N., Robishaw, N. K., Panzner, M. J., Youngs, W. J., & Yun, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300221f · Cited by 46
Gaumet, M., Gurny, R., & Delie, F. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.008 · Cited by 42
Nanoparticles as ‘smart’ pharmaceutical delivery
Chakraborty, C. (2013) · Frontiers in bioscience · doi:10.2741/4161 · Cited by 47
“Several in vitro studies have pointed out that particle size can also control the cellular uptake of nanoparticles (114, 115).”
BackgroundAlfei, S., Turrini, F., Catena, S., Zunin, P., Parodi, B., Zuccari, G., Pittaluga, A., & Boggia, R. (2019) · New Journal of Chemistry · doi:10.1039/c8nj05657a · Cited by 43
Cesur, S., Çam, M. E., Sayın, F. S., & Gündüz, O. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102977 · Cited by 42
Nanoparticles and microparticles of polymers and polysaccharides to administer fish vaccines
Rivas‐Aravena, A., Sandino, A. M., & Spencer, E. (2013) · Biological Research · doi:10.4067/s0716-97602013000400012 · Cited by 44
Kesharwani, P., Chandra, J., Karim, S., Gupta, G., Karwasra, R., & Sharma, A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105663 · Cited by 58
Qi, R., Mullen, D. G., Baker, J. R., & Holl, M. M. B. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900241t · Cited by 41
Design of nanoparticle-based dry powder pulmonary vaccines
Pulliam, B., Sung, J. C., & Edwards, D. A. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.6.651 · Cited by 47
“particles [72] and in orally administered microparticles, only particles less then 5 μm in size have been found in the mesenteric lymph nodes [73] .”
BackgroundPlangsombat, N., Rungsardthong, K., Kongkaneramit, L., Waranuch, N., & Sarisuta, N. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3661 · Cited by 46
“This may be associated with the more efficient liposome-cell membrane interactions of smaller particles compared with those of larger particles (20,21).”
Vaghasiya, K., Sharma, A., Kumar, K., Ray, E., Adlakha, S., Katare, O. P., Hota, S. K., & Verma, R. K. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01486 · Cited by 41
Size Dependency of PLGA-Nanoparticle Uptake and Antifungal Activity Against Aspergillus Flavus
Patel, N. R., Damann, K. E., Leonardi, C., & Sabliov, C. M. (2011) · Nanomedicine · doi:10.2217/nnm.11.35 · Cited by 41
In vitro evaluation of biodegradable microspheres with surface-bound ligands
Keegan, M. E., Royce, S. M., Fahmy, T. M., & Saltzman, W. M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.004 · Cited by 41
“The strong dependence of uptake by Caco-2 monolayers on particle size [22] suggests that for microspheres of the size used in this study, a different model system would be more suitable for evaluating the ability of the surface-bound ligands to increase microsphere uptake.”
BackgroundUse of lectin-functionalized particles for oral immunotherapy
Diesner, S. C., Wang, X.-Y., Jensen-Jarolim, E., Untersmayr, E., & Gabor, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.146 · Cited by 40
Aguilar, Z. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385089-8.00005-4 · Cited by 44
Amani, A., Kabiri, T., Shafiee, S., & Hamidi, A. (2019) · PubMed Central · Cited by 53
Brzeziński, M., Kost, B., Wedepohl, S., Socka, M., Biela, T., & Calderón, M. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110544 · Cited by 42
Low uptake of silica nanoparticles in Caco-2 intestinal epithelial barriers
Ye, D., Bramini, M., Hristov, D. R., Wan, S., Salvati, A. L., Åberg, C., & Dawson, K. A. (2017) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.8.141 · Cited by 40
Intracellular uptake and toxicity of three different Titanium particles
He, X., Hartlieb, E., Rothmund, L., Waschke, J., Wu, X. L., LANDUYT, K. L. V., Milz, S., Michalke, B., Hickel, R., Reichl, F., et al. (2015) · Dental Materials · doi:10.1016/j.dental.2015.03.017 · Cited by 39
Nguyen, K. T., Shukla, K. P., Moctezuma, M., Braden, A. R. C., Zhou, J. M., Hu, Z., & Tang, L. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31734 · Cited by 39
Pitarresi, G. L., Craparo, E. F., Palumbo, F. S., Carlisi, B., & Giammona, G. (2007) · Biomacromolecules · doi:10.1021/bm070224a · Cited by 39
Zha, L., Wang, M. Q., Xu, Z., & Linbo, G. U. (2007) · Biological Trace Element Research · doi:10.1007/s12011-007-0042-8 · Cited by 41
“The efficiency of uptake of 100 nm size particles by the intestinal tissues was 15- to 250-fold higher compared to larger size microparticles [18], and the significantly greater uptake of small diameter microparticles and size dependency of uptake were confirmed in Caco-2 cell lines [20].”
BackgroundSelective Gene Delivery to Cancer Cells Using an Integrated Cationic Amphiphilic Peptide
Tang, Q., Cao, B., Wu, H., & Cheng, G. (2012) · Langmuir · doi:10.1021/la303299s · Cited by 38
Nanoparticles of chromium picolinate enhance chromium digestibility and absorption
Lien, T., Yeh, H. S. J., Lu, F., & Fu, C. (2009) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.3569 · Cited by 38
Uptake and function of membrane‐destabilizing cationic nanogels for intracellular drug delivery
Liechty, W. B., Scheuerle, R. L., Ramirez, J. E. V., & Peppas, N. A. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10120 · Cited by 42
Ammulu, M. A., Konduri, V. V., Ajay Kumar, G., Mangamuri, U. K., & Sudhakar, P. (2020) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-020-00033-x · Cited by 38
The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles
Ikuta, Y., Koseki, Y., Onodera, T., Oikawa, H., & Kasai, H. (2015) · Chemical Communications · doi:10.1039/c5cc04164c · Cited by 38
Huanbutta, K., Sriamornsak, P., Luangtana‐anan, M., Limmatvapirat, S., Puttipipatkhachorn, S., Lim, L. Y., Terada, K., & Nunthanid, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.07.010 · Cited by 42
“Their higher surface area are likely to have facilitated diffusion through the transport medium (Desai et al., 1997).”
BackgroundPfeifer, B. A., Burdick, J. A., Little, S. R., & Langer, R. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.08.001 · Cited by 42
Turan, K., & Nagata, K. (2006) · Pharmaceutical Development and Technology · doi:10.1080/10837450600940873 · Cited by 38
“The nanoparticles with large size have disadvantages in the process of internalization into the cells.([20]) The particle diameter size of Ch-DNA nanoparticles prepared in this study was found to be distributed in 60–400 nm, which is comparable with the results of the previous studies([14]) Figure 3.”
Ben-David-Naim, M., Grad, E., Aizik, G., Nordling‐David, M. M., Moshel, O., Granot, Z., & Golomb, G. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.036 · Cited by 43
Derakhshandeh, K., Hochhaus, G., & Dadashzadeh, S. (2011) · PubMed Central · Cited by 37
Wong, C. Y. J., Luna, G., Martinez, J., Al‐Salami, H., & Dass, C. R. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118720 · Cited by 37
Wani, T. U., Mohi-ud-din, R., Majeed, A., Kawoosa, S., & Pottoo, F. H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200701204010 · Cited by 37
Metadata
- Authors
- Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Amidon, Gordon L.
- Venue
- Pharmaceutical Research
- Published
- 1997-11
- Volume
- 14
- Issue
- 11
- Pages
- 1568-1573
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1664986234
- Cited by
- 858
- References
- 33
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 20 · 2023: 16 · 2022: 38 · 2021: 22 · 2020: 43 · 2019: 34 · 2018: 25 · 2017: 42 · 2016: 46 · 2015: 41 · 2014: 59 · 2013: 45 · 2012: 62
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- Caco-2 cells, biodegradable microparticles, PLGA, microparticle size, intestinal absorption, bovine serum albumin, multiple emulsions, temperature dependence, concentration dependence, incubation time, intestinal epithelial cells, drug delivery systems, oral bioavailability prediction
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Cattle, Cell Membrane Permeability, Humans, Intestinal Absorption, Microspheres, Models, Biological, Particle Size, Polyglycolic Acid, Polymers, Serum Albumin, Bovine, Microscopy, Confocal, Caco-2 Cells, Lactic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.